Evidence map›Paper›PMID 37580620›Full record

ArticleNature neuroscience2023

Regional, circuit and network heterogeneity of brain abnormalities in psychiatric disorders.

Ashlea Segal, Linden Parkes, Kevin Aquino, Seyed Mostafa Kia, Thomas Wolfers, Barbara Franke, Martine Hoogman, Christian F Beckmann, Lars T Westlye, Ole A Andreassen and 14 more

Open access · hybridAbstract read
In one paragraph

Article in Nature neuroscience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 143 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
143citing papers in PubMed, 7 pooled it
39.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

143 citing papers in PubMed, 7 syntheses or guidelines pooled it, 223 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Trial
  9. Trial
  10. Article
  11. Big data and psychiatry: advances, constraints and future directions.World psychiatry : official journal of the World Psychiatric Association (WPA) · 2026
    Article
  12. New waves in psychiatric neuroimaging.Nature neuroscience · 2026
    Article
  13. Article
  14. Multiscale Heterogeneity of White Matter Morphometry in Psychiatric Disorders.Biological psychiatry. Cognitive neuroscience and neuroimaging · 2026
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

83 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 12 institutions in 7 countries.

Ashlea SegalTurner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, Melbourne, Victoria, Australia. ashlea.segal@gmail.com.ORCID http://orcid.org/0000-0002-7451-6195
Linden ParkesDepartment of Bioengineering, School of Engineering and Applied Science, University of Pennsylvania, Philadelphia, PA, USA.ORCID http://orcid.org/0000-0002-9329-7207
Kevin AquinoTurner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, Melbourne, Victoria, Australia.
Seyed Mostafa KiaDonders Centre for Cognitive Neuroimaging, Radboud University, Nijmegen, the Netherlands.
Thomas WolfersDonders Centre for Cognitive Neuroimaging, Radboud University, Nijmegen, the Netherlands.
Barbara FrankeDepartment of Psychiatry, Donders Institute of Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, the Netherlands.ORCID http://orcid.org/0000-0003-4375-6572
Martine HoogmanDepartment of Psychiatry, Donders Institute of Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, the Netherlands.
Christian F BeckmannDonders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, the Netherlands.
Lars T WestlyeNorwegian Centre for Mental Disorders Research, Division of Mental Health and Addiction, University of Oslo and Oslo University Hospital, Oslo, Norway.ORCID http://orcid.org/0000-0001-8644-956X
Ole A AndreassenNorwegian Centre for Mental Disorders Research, Division of Mental Health and Addiction, University of Oslo and Oslo University Hospital, Oslo, Norway.ORCID http://orcid.org/0000-0002-4461-3568
Andrew ZaleskyMelbourne Neuropsychiatry Centre, Department of Psychiatry, The University of Melbourne and Melbourne Health, Melbourne, Victoria, Australia.ORCID http://orcid.org/0000-0003-2298-9908
Ben J HarrisonMelbourne Neuropsychiatry Centre, Department of Psychiatry, The University of Melbourne and Melbourne Health, Melbourne, Victoria, Australia.
Christopher G DaveyDepartment of Psychiatry, University of Melbourne, Melbourne, Victoria, Australia.ORCID http://orcid.org/0000-0003-1431-3852
Carles Soriano-MasDepartment of Psychiatry, Bellvitge University Hospital, Bellvitge Biomedical Research Institute, Barcelona, Spain.ORCID http://orcid.org/0000-0003-4574-6597
Narcís CardonerCentro de Investigación Biomédica en Red de Salud Mental, Carlos III Health Institute, Madrid, Spain.ORCID http://orcid.org/0000-0001-9633-0888
Jeggan TiegoTurner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, Melbourne, Victoria, Australia.ORCID http://orcid.org/0000-0001-7835-6398
Murat YücelTurner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, Melbourne, Victoria, Australia.ORCID http://orcid.org/0000-0002-4705-452X
Leah BraganzaTurner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, Melbourne, Victoria, Australia.
Chao SuoTurner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, Melbourne, Victoria, Australia.
Michael BerkInstitute for Mental and Physical Health and Clinical Translation School of Medicine, Deakin University, Geelong, Victoria, Australia.
Sue CottonOrygen, Melbourne, Victoria, Australia.
Mark A BellgroveTurner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, Melbourne, Victoria, Australia.ORCID http://orcid.org/0000-0003-0186-8349
Andre F Marquand *Donders Centre for Cognitive Neuroimaging, Radboud University, Nijmegen, the Netherlands.ORCID http://orcid.org/0000-0001-5903-203X
Alex Fornito *Turner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, Melbourne, Victoria, Australia. alex.fornito@monash.edu.ORCID http://orcid.org/0000-0001-9134-480X
Radboud University Nijmegen · NLThe University of Melbourne · AUMonash University · AUOslo University Hospital · NOMonash Health · AUDeakin University · AUInstituto de Salud Carlos III · ESMonash Medical Centre · AUQIMR Berghofer Medical Research Institute · AURutgers, The State University of New Jersey · USThe University of Sydney · AUUniversitat Autònoma de Barcelona · ES

Funding

Mapping the Human Connectome: Structure, Function, and HeritabilityU54MH091657 · NIMH · WASHINGTON UNIVERSITY · PI UGURBIL, KAMIL, VAN ESSEN, DAVID C · 2010 to 2014
$34.7M
Training U54EB020403 · NIBIB · UNIVERSITY OF SOUTHERN CALIFORNIA · PI THOMPSON, PAUL M · 2014 to 2018
$10.1M
Discovering prognostic neuroimaging biomarkers of the psychosis spectrum using network control theoryK99MH127296 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI PARKES, LINDEN · 2021 to 2022
$146k
NIBIB NIH HHS U54 EB020403NIMH NIH HHS K99 MH127296NIMH NIH HHS U54 MH091657Wellcome Trust
6 · The paper itself

Abstract

The substantial individual heterogeneity that characterizes people with mental illness is often ignored by classical case-control research, which relies on group mean comparisons. Here we present a comprehensive, multiscale characterization of the heterogeneity of gray matter volume (GMV) differences in 1,294 cases diagnosed with one of six conditions (attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, depression, obsessive-compulsive disorder and schizophrenia) and 1,465 matched controls. Normative models indicated that person-specific deviations from population expectations for regional GMV were highly heterogeneous, affecting the same area in <7% of people with the same diagnosis. However, these deviations were embedded within common functional circuits and networks in up to 56% of cases. The salience-ventral attention system was implicated transdiagnostically, with other systems selectively involved in depression, bipolar disorder, schizophrenia and attention-deficit/hyperactivity disorder. Phenotypic differences between cases assigned the same diagnosis may thus arise from the heterogeneous localization of specific regional deviations, whereas phenotypic similarities may be attributable to the dysfunction of common functional circuits and networks.

Indexed as

Attention Deficit Disorder with HyperactivityAutism Spectrum DisorderBipolar DisorderObsessive-Compulsive DisorderBrainGray MatterHumansMagnetic Resonance Imaging

Identifiers

PMID37580620
PMCPMC10471501
OpenAlexW4385805479

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.